Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?
Five-Factor Model
Type D personality
cancer
cancer medications
chemotherapy
medication adherence
medication persistence
oncology
oral anticancer therapy
Journal
JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
16
02
2024
accepted:
31
07
2024
revised:
03
05
2024
medline:
31
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
Adherence to prescribed oral anticancer therapy is an important determinant of patient outcomes, including progression-free and overall survival. While many factors (eg, medication side effects and out-of-pocket costs, problems with insurance authorization, and timely medication refills) can affect adherence, one that is relatively unexplored is the impact of a patient's attitude and personality. Patient personality influences medication adherence and persistence in nonmalignant chronic conditions such as cardiovascular disease and diabetes. In breast cancer and chronic myeloid leukemia, studies suggest that personality also affects adherence to oral chemotherapy which can be targeted to improve adherence. In this viewpoint, we highlight the opportunity of incorporating patient personality as interventions to oral cancer therapy adherence and discuss current barriers to implementation.
Identifiants
pubmed: 39475848
pii: v10i1e57199
doi: 10.2196/57199
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e57199Informations de copyright
©Mahtab Jafari, Alex Shahverdian, Gelareh Sadigh, Richard A Van Etten. Originally published in JMIR Cancer (https://cancer.jmir.org), 30.10.2024.